US Stock MarketDetailed Quotes

GOSS Gossamer Bio

Watchlist
  • 0.698
  • -0.004-0.51%
Close Nov 29 13:00 ET
  • 0.715
  • +0.017+2.42%
Post 17:01 ET
158.19MMarket Cap-2792P/E (TTM)

About Gossamer Bio Company

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi in 2015 and is headquartered in San Diego, CA.

Company Profile

SymbolGOSS
Company NameGossamer Bio
Listing DateFeb 8, 2019
Issue Price16.00
Founded2015
CEOMr. Faheem Hasnain
MarketNASDAQ
Employees135
Fiscal Year Ends12-31
Address3013 Science Park Road,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-684-1300
Websitehttp://www.gossamerbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Faheem Hasnain
  • Chairman of the Board, President and Chief Executive Officer
  • 2.10M
  • Bob Smith
  • Chief Commercial Officer
  • 1.33M
  • Bryan Giraudo
  • Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
  • 1.29M
  • Dr. Richard Aranda, M.D.
  • Chief Medical Officer
  • --
  • Christian Waage
  • Executive Vice President, Technical Operations and Administration
  • --
  • Caryn Peterson
  • Executive Vice President, Regulatory Affairs
  • --
  • Dr. Steven Nathan, M.D.
  • Independent Director
  • --
  • Dr. Thomas O. Daniel, M.D.
  • Lead Independent Director
  • 98.82K
  • Skye Drynan
  • Independent Director
  • --
  • Dr. John D. Quisel, J.D.,PhD
  • Independent Director
  • 133.61K
  • Dr. Sandra Milligan, J.D.
  • Independent Director
  • 81.82K
  • Russell J. Cox
  • Independent Director
  • 87.32K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data